Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKeros Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$0.79 | -$0.61 | -$0.69 |
| Q2 2025 | 4 | -$1.23 | -$1.23 | -$1.23 |
| Q3 2025 | 4 | -$1.19 | -$1.19 | -$1.19 |
| Q4 2025 | 4 | -$1.22 | -$1.22 | -$1.22 |
| Q1 2026 | 3 | -$0.98 | -$0.98 | -$0.98 |
| Q2 2026 | 3 | -$0.98 | -$0.98 | -$0.98 |
| Q3 2026 | 3 | -$0.98 | -$0.98 | -$0.98 |
| Q4 2026 | 3 | -$0.98 | -$0.98 | -$0.98 |
Keros Therapeutics, Inc. Earnings Date And Information
Keros Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-1.41 earnings per share for the quarter, missing analysts' consensus estimates of $-1.26 by $0.15. The company had revenue of 388,000 for the quarter and had revenue of 151,000 for the year. Keros Therapeutics, Inc. has generated $-5 earnings per share over the last year ($-5.2 diluted earnings per share) and currently has a price-to-earnings ratio of -2.39. Keros Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Keros Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$1.26 | -$1.47 | -0.21 | $388,000 | $388,000 |
| 08/07/2024 | Q2 2024 | -$1.23 | -$1.25 | -0.02 | $37,000 | $37,000 |
| 05/08/2024 | Q1 2024 | -$1.31 | -$1.46 | -0.15 | $83,000 | |
| 12/30/2023 | Q4 2023 | -$1.34 | $143,000 | |||
| 11/06/2023 | Q3 2023 | -$1.34 | -$1.33 | 0.01 | $8,000 | |
| 08/07/2023 | Q2 2023 | -$1.34 | -$1.27 | 0.07 | $216,667 | $0 |
| 05/04/2023 | Q1 2023 | -$1.13 | -$1.15 | -0.02 | $0 | |
| 03/03/2023 | Q4 2022 | -$1.12 | -$1.09 | 0.03 | $0 | |
| 11/03/2022 | Q3 2022 | -$1.26 | -$0.75 | 0.51 | $0 | |
| 08/04/2022 | Q2 2022 | -$1.07 | -$0.99 | 0.08 | $100,000 | |
| 05/05/2022 | Q1 2022 | -$0.86 | -$1.01 | -0.15 | $0 | |
| 03/09/2022 | Q4 2021 | -$0.94 | -$0.30 | 0.64 | $20.00 M | |
| 11/04/2021 | Q3 2021 | -$0.72 | -$0.87 | -0.15 | $0 | |
| 08/05/2021 | Q2 2021 | -$0.66 | -$0.67 | -0.01 | $100,000 | |
| 05/06/2021 | Q1 2021 | -$0.58 | -$0.68 | -0.1 | $0 | |
| 03/25/2021 | Q4 2020 | -$0.57 | -$0.49 | 0.08 | $0 | |
| 11/10/2020 | Q3 2020 | -$0.58 | -$0.60 | -0.02 | $62,500 | $2.50 M |
| 08/13/2020 | Q2 2020 | -$0.51 | -$0.61 | -0.1 | $2.50 M | |
| 05/22/2020 | Q1 2020 | -$0.65 | $2.50 M | |||
| 12/30/2019 | Q4 2019 | -$0.31 | $2.50 M |
Keros Therapeutics, Inc. Earnings: FAQ's
When is Keros Therapeutics, Inc.'s earnings date?
Keros Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
How can I listen to Keros Therapeutics, Inc.'s earnings conference
call?
The conference call for Keros Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Keros Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Keros Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Keros Therapeutics, Inc. generate each year?
Keros Therapeutics, Inc. (:KROS) has a recorded annual revenue of $151,000.
How much profit does Keros Therapeutics, Inc. generate each year?
Keros Therapeutics, Inc. (:KROS) has a recorded net income of $151,000. Keros Therapeutics, Inc. has generated $-5.2 earnings per share over the last four quarters.
What is Keros Therapeutics, Inc.'s price-to-earnings ratio?
Keros Therapeutics, Inc. (:KROS) has a price-to-earnings ratio of -2.39 and price/earnings-to-growth ratio is 0.92.